Affiliations 

  • 1 Department of Physics, Faculty of Science, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia
  • 2 Department of Radiology, National Cancer Institute, Precint 7, 62250 Putrajaya, Malaysia
  • 3 Department of Quantum Medical Technology, Faculty of Health Sciences, Kanazawa University, Japan
  • 4 Department of Physics, Faculty of Science, Universiti Teknologi Malaysia Johor Baru, Malaysia
  • 5 Department of Physics, College of Science, Imam Abdurrahman Bin Faisal University, Saudi Arabia, City Dammam, Saudi Arabia
J Xray Sci Technol, 2019;27(1):139-147.
PMID: 30584178 DOI: 10.3233/XST-180397

Abstract

BACKGROUND: Numerous techniques had been proposed to reduce radiation exposure in computed tomography (CT) including the use of radiation shielding.

OBJECTIVE: This study aims to evaluate efficacy of using a bismuth breast shield and optimized scanning parameter to reduce breast absorbed doses from CT thorax examination.

METHODS: Five protocols comprising the standard CT thorax clinical protocol (CP1) and four modified protocols (CP2 to CP5) were applied in anthropomorphic phantom scans. The phantom was configured as a female by placing a breast component on the chest. The breast component was divided into four quadrants, where 2 thermoluminescence dosimeters (TLD-100) were inserted into each quadrant to measure the absorbed dose. The bismuth shield was placed over the breast component during CP4 and CP5 scans.

RESULTS: The pattern of absorbed doses in each breast and quadrant were approximately the same for all protocols, where the 4th quadrant > 3rd quadrant > 2nd quadrant > 1st quadrant. The mean absorbed dose value in CP3 was reduced to almost 34% of CP1's mean absorbed dose. It was reduced even lower to 15% of CP1's mean absorbed dose when the breast shield was used in CP5.

CONCLUSION: This study showed that CT radiation exposure on the breast could be reduced by using a bismuth shield and low tube potential protocol without compromising the image quality.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.